Calton & Associates’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-2,378
Closed -$330K – 260
2022
Q1
$330K Buy
+2,378
New +$364K 0.1% 229
2018
Q3
– Sell
-2,115
Closed -$298K – 293
2018
Q2
$298K Buy
+2,115
New +$261K 0.09% 187
2018
Q1
– Sell
-346
Closed -$49K – 494
2017
Q4
$49K Buy
+346
New +$47.1K 0.01% 689

Other funds holding CLX

Calton & Associates's CLX Position: Q2 2022 in Review

Calton & Associates sold out of Clorox (CLX) in Q2 2022, closing a stake of 2,378 shares — an estimated $330K sold.

Calton & Associates first reported a position in CLX in Q4 2017 and held it in 3 quarters. The position peaked at $330K in Q1 2022. 1,081 funds tracked by Wall St. Rank hold CLX as of Q2 2022.

  • Calton & Associates reported no remaining Clorox position as of Q2 2022 after selling out during the quarter.
  • Calton & Associates sold 2,378 Clorox shares in Q2 2022, an estimated $330K.
  • Calton & Associates first reported a position in Clorox in Q4 2017 and held it in 3 quarters.
  • Calton & Associates's Clorox position peaked at $330K in Q1 2022.
  • 1,081 funds tracked by Wall St. Rank held Clorox as of Q2 2022.

Based on Calton & Associates's 13F filing for Q2 2022, filed 12 Jul 2022.